State of Wyoming - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
State of Wyoming ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
8
-99.3%
0.00%
-100.0%
Q1 2022$36,000
+100.0%
1,134
+193.8%
0.02%
+125.0%
Q4 2021$18,000
+350.0%
386
+451.4%
0.01%
+166.7%
Q3 2021$4,000
-84.6%
70
-79.2%
0.00%
-81.2%
Q2 2021$26,000
+62.5%
337
+21.7%
0.02%
-38.5%
Q1 2021$16,0002770.03%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders